Want to join the conversation?
Generics and specialty pharmaceutical company $MYL posted higher net income of $194MM or $0.38 per diluted share vs. $189MM or $0.47 per diluted share in 4Q14. Total revenues rose 19.6% to $2.5Bil vs. 4Q14, helped by increases in Generics segment third party net sales of 22% and Specialty segment reported third party net sales of 5%.
Great results from $TSLA, however the question remains if Tesla can continue to scale up to produce the cars in the quantity it promises. Model 3 numbers need to be in multiples of what they are producing right now. Wish them the best, will keep an eye as I am still not convinced that they can scale easily.
Watching $TSLA Oct 28th $215 Calls for possible entry
Chipotle stock is crashing like a falling knife after it's earnings report last evening; down about 10% already today! Was Bill Ackman wrong in buying about 10% stake in $CMG couple of months ago? Or is this market reacting to disappointing earnings? And can they really get customers to trust them again after food-safety crisis?
$TSLA Just recalling Elon Musk's statement during Q4 earnings. "I am presently quite excited about is that we expect to be positive cash flow starting next month, and then continuing on into Q2 and beyond." Will the electric carmaker prove that it can be cash flow positive company this quarter?